News Medical on MSN1d
Engineering safe and effective vaccinia virus vectors for next-generation vaccinesAnnouncing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...
How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...
A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...
Infectious disease specialist considers the possibility of an outbreak of yellow fever in the DR low
Infectious disease specialist Jesús Feris Iglesias believes that the Dominican Republic does not have the conditions for an outbreak of yellow fever at some point. It has neither jungle nor monkeys, ...
Ugandan authorities launched a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one nurse in the ...
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
The other COVID-19 vaccines authorised for use in the EU are mRNA vaccines (Pfizer/BioNTech and Moderna) or viral vector vaccines (AstraZeneca and Janssen).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback